logo

For the Inventor, By the Inventor

Cornwall, NY, United States of America

Ingrid Lea Scully

This inventor holds 8 USPTO granted patents and 4 published patent applications. Top assignees: Wyeth, Pfizer Corporation, Regents of the University of Minnesota. Active years: 2013-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ingrid Lea Scully. Retrieved from https://idiyas.com/inventor/ingrid-lea-scully

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0

Average Co-Inventor Count = 9.3

ph-index = 4

Forward Citations = 40(Granted Patents)


Company Filing History:

goldMedal6 out of 1,309 
 
Wyeth
 patents
silverMedal2 out of 4,488 
 
Pfizer Corporation
 patents
bronzeMedal1 out of 2,372 
 
Regents of the University of Minnesota
 patents
where one patent can have more than one assignee

Years Active: 2013-2021

Loading Chart...
8 patents (USPTO):Explore Patents
1. 10946086 - Group Bpolysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof (2021-03-16),
2. 10226525 - [object Object] (2019-03-12),
3. 9623100 - [object Object] (2017-04-18),
4. 9127050 - Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (BHS) disease (2015-09-08),
5. 9125951 - [object Object] (2015-09-08),
6. 9114105 - [object Object] (2015-08-25),
7. 8889145 - [object Object] (2014-11-18),
8. 8568735 - [object Object] (2013-10-29),

Title: Ingrid Lea Scully: Pioneering Innovations in Immunogenic Compositions.

Introduction: Ingrid Lea Scully, a visionary inventor based in Cornwall, NY, is renowned for her groundbreaking work in the field of immunogenic compositions. With a total of 8 patents to her name, Scully's passion for innovation and dedication to sustainability have captivated the next generation of inventors.

Latest Patents: Among her notable inventions is a series of immunogenic polysaccharide-protein conjugates designed to combat Group B Streptococcus (GBS) infections. These conjugates, which incorporate specific GBS serotypes and carrier proteins, aim to induce immune responses and prevent invasive GBS diseases.

Career Highlights: Scully's career has been marked by impactful roles at leading pharmaceutical companies, including Wyeth and Pfizer Corporation. Her innovative spirit and unwavering commitment to advancing medical solutions have set new standards in the industry.

Collaborations: Throughout her journey, Scully has collaborated closely with talented individuals such as Annaliesa Sybil Anderson and Kathrin Ute Jansen. Together, they have pushed the boundaries of immunology and made significant strides in developing lifesaving therapies.

Conclusion: Ingrid Lea Scully's remarkable contributions to the field of immunogenic compositions serve as a testament to her ingenuity and dedication. Her work not only inspires the current generation of inventors but also holds the promise of a healthier future for all.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…